Basic requirements for the use of terms for reporting adverse drug reactions (IV)-Reference-Cited by-同舟云学术

Basic requirements for the use of terms for reporting adverse drug reactions (IV)

Published:1993-03 Issue:2 Volume:2 Page:149-153
ISSN:1053-8569
Container-title:Pharmacoepidemiology & Drug Safety
language:en
Short-container-title:Pharmacoepidem. Drug Safe.

Author:

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Reference4 articles.

1. Report of the Third Annual Meeting of Representatives of National Centres participating in the WHO Drug Monitoring Programme, 11–13 November 1980. WHO Offset Document (DEM/81.1), Annex 2. Geneva, World Health Organization, 1981.

2. Basic requirements for the use of terms for reporting adverse drug reactions

3. Basic requirements for the use of terms for reporting adverse drug reactions (II)

4. Basic requirements for the use of terms for reporting adverse drug reactions (III)

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Definitions and basic requirements for the use of terms for reporting adverse drug reactions (XIII): clinical pathology and general disorders;Pharmacoepidemiology and Drug Safety;1999-05

2. Definitions and basic requirements for the use of terms for reporting adverse drug reactions (XII): collagen disorders and musculo-skeletal disorders;Pharmacoepidemiology and Drug Safety;1999-03

3. Communication in pharmacovigilance;Pharmacoepidemiology & Drug Safety;1994-05

4. The medical dictionary for drug regulatory affairs (MEDDRA) project;Pharmacoepidemiology & Drug Safety;1994-01

5. Definitions of adverse drug reactions and minimum requirements for their use — cardiovascular disease terms;Pharmacoepidemiology & Drug Safety;1993-11